ERIS Lifesciences Limited – Acquisition Led Growth Story
Eris Lifesciences Limited (ERIS IN) is engaged in the marketing and manufacturing of branded generic drugs and derives all its revenues from the...
217 Views
Smartkarma: ECM Coverage Weekly Update (1 July 2017)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week, Tejas...
185 Views
Eris Lifesciences IPO - Rich Valuations at What Appears to Be Unsustainably High Margins
Eris Lifesciences plans to raise US$270m in its IPO through a selldown of shares by a ChrysCapital, a PE investor, and the founders. Our fellow...
472 Views
Eris Lifesciences: Ask Some Questions, Take the Deal
Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...
539 Views